Intervention: Bevacizumab HAI plus systemic chemotherapy
Found 17 matching trials
Phase II Study Comparing Conversion Rate to Surgery With Hepatic Arterial Infusion Chemotherapy to Systemic Chemotherapy in Patients With Non Resectable Liver-only Colorectal Metastases
PHASE2
Approximately 40% of colorectal cancer patients will develop colorectal liv...
Status
Unknown
Location
Severance Hospital, Yonsei University Health System
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
PHASE3
This phase III trial compares hepatic arterial infusion (HAI) (pump chemoth...
FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients
PHASE2
This prospective, randomized, controlled clinical study aims to evaluate th...